Cargando…
Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States
Newborn screening for congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency is mandated throughout the US. Filter paper blood specimens are assayed for 17-hydroxyprogesterone (17OHP). Prematurity, low birth weight, or critical illness cause falsely elevated results. The purpose of...
Autores principales: | Speiser, Phyllis W., Chawla, Reeti, Chen, Ming, Diaz-Thomas, Alicia, Finlayson, Courtney, Rutter, Meilan M., Sandberg, David E., Shimy, Kim, Talib, Rashida, Cerise, Jane, Vilain, Eric, Délot, Emmanuèle C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422998/ https://www.ncbi.nlm.nih.gov/pubmed/32832708 http://dx.doi.org/10.3390/ijns6020037 |
Ejemplares similares
-
SAT-LB050 Congenital Adrenal Hyperplasia Newborn Screening Protocols Differ Widely in the US: A Survey by the Differences/Disorders of Sex Development Translational Research Network (DSD-TRN)
por: Speiser, Phyllis, et al.
Publicado: (2019) -
Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015) -
Emerging medical therapies for congenital adrenal hyperplasia
por: Speiser, Phyllis W.
Publicado: (2019) -
Nonvirilized Genitalia in 3 Female Newborns With the Salt-Wasting Congenital Adrenal Hyperplasia Phenotype
por: Yauch, Lauren, et al.
Publicado: (2020) -
Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
por: Balsamo, Antonio, et al.
Publicado: (2020)